Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 193

Sort by

Sort Order Select

Journal Articles

Artificial intelligence-based diagnosis of myelodysplastic syndromes/neoplasms using bone marrow

Palak Dave, Ling Zhang, Joseph Pierce, Sameer Andani, Jordan Rai, Mohammad Hussaini, Mary Ellen Walker, Nancy Gillis, Lynn Moscinski, Mikkael Sekeres, Amy DeZern, Eric Padron, Rami Komrokji, Issam El Naqa

Blood (2025) 146 (Supplement 1): 5642.

https://doi.org/10.1182/blood-2025-5642

Published: 2025

Journal Articles

Clinical, genetic, and pathologic differences across race, ethnicity, and sex in patients with MDS and precursor conditions from the national MDS natural history study

Blood (2025) 146 (Supplement 1): 3845.

https://doi.org/10.1182/blood-2025-3845

Published: 2025

Journal Articles

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Ekrem Turk, Fernando Bustamante, Fatima Tuz Zahra, Yu-Han Chen, Rory Shallis, Onyee Chan, Samuel Reynolds, Alison Walker, Ling Zhang, Seongseok Yun, Jeffrey Lancet, David Sallman, Rami Komrokji, Jinming Song, Eric Padron, Gabriela Hobbs, Andrew Kuykendall, Zhuoer Xie

Blood (2025) 146 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2025-3815

Published: 2025

Journal Articles

Heterogeneity of circulating CD57+ cytotoxic cell subsets across disease stage and aggressiveness in cutaneous T cell lymphoma

Sara Niyazi, Ahmed Arfa, Tobi Ozoya, Kimberly Ward, Lalith Roopesh, Jeffrey West, Javier Pinilla-Ibarz, Ling Zhang, Lubomir Sokol, Dietrich Werner Idiaquez, Christopher Ryder, Yumeng Zhang

Blood (2025) 146 (Supplement 1): 3644.

https://doi.org/10.1182/blood-2025-3644

Published: 2025

Journal Articles

Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium

Blood (2025) 146 (Supplement 1): 904.

https://doi.org/10.1182/blood-2025-904

Published: 2025

Journal Articles

Direct small molecule inhibition of RAS enhances JAK2 inhibitor therapy in preclinical models of myeloproliferative neoplasms

Garima Pandey, Tegan Rowsell, Lucia Mazzacurati, Andrew Kuykendall, Ling Zhang, Gary Reuther

Blood (2025) 146 (Supplement 1): 5533.

https://doi.org/10.1182/blood-2025-5533

Published: 2025

Journal Articles

Rare cancer, rare survivors: A 20-year single-center review of adult T-cell lymphoma/leukemia treatment outcomes

Yumeng Zhang, Hayder Saeed, Amin Azem, Jose Sandoval-Sus, Fatima Tuz Zahra, Kavita Ghia, Abu-Sayeef Mirza, Bijal Shah, Celeste Bello, Javier Pinilla-Ibarz, Ling Zhang, Lubomir Sokol

Blood (2025) 146 (Supplement 1): 7161.

https://doi.org/10.1182/blood-2025-7161

Published: 2025

Journal Articles

XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies

Blood (2025) 146 (18): 2244–2258.

https://doi.org/10.1182/blood.2025028803

Published: 2025

Includes: Supplemental data

Journal Articles

A Phase I Study of Duvelisib in Combination with Oral Azacitidine (BMS-986345) in Mature T Cell Lymphoma

Hayder Saeed, Melanie Mediavilla Varela, Eva Sahakian, Mahrukh Naqvi, Qiangxing Mo, Ling Zhang, Rikesh Makanji, Yumeng Zhang, Ning Dong, Leidy Lismeris Isenalumhe, Sameh Gaballa, Julio C. Chavez, Bijal D Shah, Celeste M. Bello, Lubomir Sokol, Javier Pinilla-Ibarz

Blood (2024) 144 (Supplement 1): 3065.

https://doi.org/10.1182/blood-2024-205173

Published: 2024

Journal Articles

Synchronous Dual Hematologic Neoplasms of Myeloid and Lymphoid Lineage Are of Common Clonal Origin

Blood (2024) 144 (Supplement 1): 4578.

https://doi.org/10.1182/blood-2024-210599

Published: 2024

Journal Articles

Association between Smoking Intensity, Genetic Mutations, and Disease Progression in Myelodysplastic Syndromes

Blood (2024) 144 (Supplement 1): 4597.

https://doi.org/10.1182/blood-2024-206034

Published: 2024

Journal Articles

Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS)

Blood (2024) 144 (Supplement 1): 1831.

https://doi.org/10.1182/blood-2024-201613

Published: 2024

Journal Articles

Quantification of Transition Rates in B-Cell Acute Lymphoblastic Leukemia Identifies Structural Relationships between Cell States

Curtis Gravenmier, Sadegh Marzban, Ling Zhang, Lynn C. Moscinski, Jeffrey West

Blood (2024) 144 (Supplement 1): 4979.

https://doi.org/10.1182/blood-2024-208455

Published: 2024

Journal Articles

Mechanistic Learning Reveals the Reciprocal Cell Fate Transitions That Drive Disease Progression in B-Cell Acute Lymphoblastic Leukemia

Sadegh Marzban, Curtis Gravenmier, Ling Zhang, Lynn C. Moscinski, Jeffrey West

Blood (2024) 144 (Supplement 1): 2229.

https://doi.org/10.1182/blood-2024-205677

Published: 2024

Journal Articles

Robust Copy Number Alteration Detection (RCNA): A Novel Algorithm for Detecting Copy-Number Alterations for Targeted Gene Sequencing Experiments

Travis L Jensen, Matthew D Bradley, Ling Zhang, Rafael Bejar, R. Coleman Lindsley, Matthew J. Walter, Johannes Goll

Blood (2024) 144 (Supplement 1): 3220.

https://doi.org/10.1182/blood-2024-210552

Published: 2024

Journal Articles

Impact of Clonal T-LGL Populations in Peripheral Blood on Clinical Outcomes in Cutaneous T-Cell Lymphoma

Sara Niyazi, Xiaoqing Yu, Carly Harro, Lewis Glass, Lubomir Sokol, Jose Conejo-Garcia, Ling Zhang, Yumeng Zhang

Blood (2024) 144 (Supplement 1): 3060.

https://doi.org/10.1182/blood-2024-202658

Published: 2024

Journal Articles

Clinical Relevance of Subgrouping in TP53 mutated Myelodysplastic Neoplasms: Insights from ICC and Who Classifications

Hammad Tashkandi, Xiaohui Zhang, Rami S. Komrokji, Najla H. Al Ali, Zhuoer Xie, Alison R. Walker, Eric Padron, Jeffrey E Lancet, David Sallman, Ling Zhang

Blood (2024) 144 (Supplement 1): 3227.

https://doi.org/10.1182/blood-2024-211460

Published: 2024

Journal Articles

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Prolymphocytic Leukemia: Two Case Reports

Sihan Lai, Yisong Xiong, Yanrong Shuai, Xupai Zhang, Guangcui He, Hao Yao, Hui Yang, Ling Zhang, Rong Huang, Yi Su, Alex H. Chang, Hai Yi

Blood (2024) 144 (Supplement 1): 7204.

https://doi.org/10.1182/blood-2024-202015

Published: 2024

Journal Articles

A Deep-Learning Pipeline for Diagnosis of Myelodysplastic Syndromes/Neoplasms Using Bone Marrow Smears

Palak Dave, Jordan Rai, Ling Zhang, Mohammad Omar Hussaini, Mary Ellen Walker, Nancy Gillis, Mikkael A. Sekeres, Amy E. DeZern, Eric Padron, Rami S. Komrokji, Issam El Naqa

Blood (2024) 144 (Supplement 1): 4991.

https://doi.org/10.1182/blood-2024-207735

Published: 2024

Journal Articles

A Phase 2 Study of Fedratinib in Patients with MDS/MPN and Chronic Neutrophilic Leukemia

Andrew T. Kuykendall, Tania Jain, Abhay Singh, Kristen M. Pettit, Quan Lovette, Joan McFadden Cain, Tracy Ann Cinalli, Mary Gallagher, David Sallman, Qianxing Mo, Ling Zhang, Onyee Chan, Alison R. Walker, Zhuoer Xie, Jeffrey E Lancet, Maria Balasis, Seongseok Yun, Eric Padron, Rami S. Komrokji

Blood (2024) 144 (Supplement 1): 481.

https://doi.org/10.1182/blood-2024-210743

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Artificial intelligence-based diagnosis of myelodysplastic syndromes/neoplasms using bone marrow

Clinical, genetic, and pathologic differences across race, ethnicity, and sex in patients with MDS and precursor conditions from the national MDS natural history study

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Heterogeneity of circulating CD57+ cytotoxic cell subsets across disease stage and aggressiveness in cutaneous T cell lymphoma

Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium

Direct small molecule inhibition of RAS enhances JAK2 inhibitor therapy in preclinical models of myeloproliferative neoplasms

Rare cancer, rare survivors: A 20-year single-center review of adult T-cell lymphoma/leukemia treatment outcomes

XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies

A Phase I Study of Duvelisib in Combination with Oral Azacitidine (BMS-986345) in Mature T Cell Lymphoma

Synchronous Dual Hematologic Neoplasms of Myeloid and Lymphoid Lineage Are of Common Clonal Origin

Association between Smoking Intensity, Genetic Mutations, and Disease Progression in Myelodysplastic Syndromes

Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS)

Quantification of Transition Rates in B-Cell Acute Lymphoblastic Leukemia Identifies Structural Relationships between Cell States

Mechanistic Learning Reveals the Reciprocal Cell Fate Transitions That Drive Disease Progression in B-Cell Acute Lymphoblastic Leukemia

Robust Copy Number Alteration Detection (RCNA): A Novel Algorithm for Detecting Copy-Number Alterations for Targeted Gene Sequencing Experiments

Impact of Clonal T-LGL Populations in Peripheral Blood on Clinical Outcomes in Cutaneous T-Cell Lymphoma

Clinical Relevance of Subgrouping in TP53 mutated Myelodysplastic Neoplasms: Insights from ICC and Who Classifications

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Prolymphocytic Leukemia: Two Case Reports

A Deep-Learning Pipeline for Diagnosis of Myelodysplastic Syndromes/Neoplasms Using Bone Marrow Smears

A Phase 2 Study of Fedratinib in Patients with MDS/MPN and Chronic Neutrophilic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only